Clinical Trials

Members: 28
Latest Activity: Jun 16, 2023

Discussion Forum

All Sickle cell trials in the US

Started by Ade Dotun Nov 15, 2017. 0 Replies

New site I found where you can look for trials in your country:…Continue

Do members understand how new medicines for SC illness are developed?

Started by Carl Kollmer, Pfizer Feb 20, 2016. 0 Replies

I am curious about the general level of knowledge about the process for developing new medicines.For example:-The three phases of clinical trials (phase 1, 2, 3),-The process for informing…Continue

What information would you need to feel comfortable participating in a clinical trial? Who would you seek advice from?

Started by Carl Kollmer, Pfizer. Last reply by Carlyle Dec 15, 2015. 3 Replies

I am curious as to how different individuals would go about evaluating whether or not a clinical trial is right for them, weighing risks and potential benefits.  What resources would you use to…Continue

Comment Wall


You need to be a member of Clinical Trials to add comments!

Comment by Katie on June 16, 2023 at 3:56pm

The Women’s Health Clinical Research Center at Penn Medicine is currently recruiting participants with sickle cell disease for a paid study looking at whether participants experience any difference in their sickle cell pain while using a hormonal birth control implant as compared to when not using this birth control method. The implant, known as Nexplanon, is currently FDA approved, releases a small amount of hormone every day, and is the most effective form of hormonal contraception.

Participants in the study will have 4-5 in-person visits during the 9 months of the study, and can receive up to $530 for completing all parts of the study. Participants should be close enough to the Philadelphia area to attend in-person visits.

If this is something you may be interested in learning more about, please click here to fill out a survey to determine if you are eligible.

Thank you!


Members (28)


© 2024   Created by Ade Dotun.   Powered by

Badges  |  Report an Issue  |  Privacy Policy  |  Terms of Service